Global Bioreactors Market Trends for Non-food Applications, Segmentation By Product (Single-use, Multi-use), By Construction Material (Stainless Steel, Glass, Others), By Application (Biotechnology & Pharmaceutical, Contract Research Organizations (CROs), Others), By Region And Forecast From 2018 to 2025
Dec 2018
Total Pages: 100
Choose License Type
The global bioreactors market size crossed USD 1.70 billion in 2017. Rising investment in biotechnology & pharmaceutical sector and significant demand for stainless steel as a choice of the reactor construction material are some of the key driving bioreactors market trends. North America and Europe accounted for a significant bioreactor market share among other regions in 2017, owing to high product utilization in pharmaceutical, biotechnology and research & development.
Global Bioreactors Market Trends, 2017- 2025 (USD Billion)
Single-use and multi-use bioreactors are the key product segments of the market. Single use bioreactor market is likely to increase at the fastest growth rate during the forecast period. A single-use bioreactor typically contains a disposable bag in place of a culture vessel. These products utilize a sterilized cell chamber in which the cell culture is maintained. The cell chamber reduces the cross-contamination risks as it is used for single growth operation. Furthermore, the use of single-use bioreactors optimizes the sterilization, cleaning, validation, and maintenance procedures needed for each bioreactor run.
The single use bioreactor market demand is expected to rise in pharmaceutical and R&D applications, owing to the key attributes of the product. High flexibility in terms of usage, less downtime, and controlled microbial contamination are some of the key attributes exhibited by the single-use bioreactors.
Multi-use or reusable bioreactors can be used numerous times. Reusable bioreactors require expensive and bulky clean-in-place (CIP) or steam-in-place (SIP) installations. The disposable bag of the single-use bioprocessors avoids the need to use CIP and SIP systems. The disposable bags are usually made of a three-layer plastic foil, with the layers frequently consisting of polyethylene, PVA, PVC, and polypropylene combinations to minimize leakage. The multi-use bioreactor segment accounted for more than two-third share of the global bioreactors market size in 2017.
The end-uses or applications that have supported strong bioreactors market trends include contract research organizations (CROs), biotechnology & pharmaceutical, and others. Contract research organizations (CROs) are a key constituent of the drug development process, providing a range of services to pharmaceutical, biotechnology, and medical device companies, as well as governments, academic institutions, and other research entities.
Single-use bioreactors are extensively used in CROs. CROs typically handle different products on account of which it is economical to use disposable bags in place of a stainless-steel vessel. The growing number of CROs is expected to augment the growth of the single use bioreactor market industry over the next few years.
U.S. was the largest market for biopharmaceuticals in North America. A large number of pipelines within the healthcare sector is expected to give rise to a large number of clinical trials which is likely to boost the global bioreactors market size by 2025. In addition, increasing trends of outsourcing by biopharma companies to CROs is expected to enhance the bioreactors market trends in the country, over the years ahead. North America and Europe are anticipated to portray strong bioreactors market trends during the forecast period.
Global Bioreactor Market Share, By Region, 2017 (%)
Europe has made significant advances in health outcomes over the past 60 years. The life expectancy of individuals has increased by nearly a decade, and effective treatments have become available for many of the most common infectious diseases. At the same time, biomedical R&D is breaking new ground in understanding patients’ specific genetic characteristics, paving the way for targeted, more effective therapies based on personalized medicine. Europe needs to continue this trend, but it will require new models for innovation and adaptation on all levels across the healthcare delivery chain. These factors are expected to boost the bioreactor market share of Europe by the end of 2025.
Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Limited, Danaher (Pall Corporation), Eppendorf AG, Praj HiPurity Systems Limited, Pierre Guerin, Zeta Holding GmbH, and Applikon Biotechnology B.V. are the key players that accounted for a significant share of the global bioreactors market size in 2017.
Key segments of the global bioreactors market for non-food applications report
Product Overview, 2012-2025 (USD Million)
- Single-use
- Multi-use
Construction Material Overview, 2012-2025 (USD Million)
- Stainless steel
- Glass
- Others
Application Overview, 2012-2025 (USD Million)
- Biotechnology & pharmaceutical
- Contract research organizations (CROs)
- Others
Regional Overview, 2012-2025 (USD Million)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- South Korea
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Rest of MEA
Reasons for the study
The purpose of the study is to provide a broad view of the global bioreactors market.
- We have been analyzing the recent growth trends of biotechnology, pharmaceutical, and research & development sectors. This further helped us in understanding the usage of bioreactors.
- Modification in bioreactors designs, adoption of the product in each geography are some of the trends analyzed while working on the study
- Competence of the top global players through their product offerings and geographical coverage are some of the other industry trends that have been taken into consideration for studying the bioreactors market
What does the report include?
- The study on the global bioreactors market includes qualitative market dynamics such as drivers, restraints, and opportunities
- Additionally, the market has been evaluated using the value chain, PESTEL analysis and Porter’s Five Forces analysis
- The study includes qualitative and quantitative analysis of the market categorized on the basis of product type, construction material, application and region
- Actual market sizes and forecast figures have been provided for all the afore-mentioned market segments
- The report also covers profiling of key industry players that have a significant global and/or regional presence
Who should buy this report?
This study is suitable for industry participants and stakeholders in the biotechnology, CROs and pharmaceutical industries, who want an in-depth insight into the development of the bioreactors market. The report will benefit:
- Executives of companies that are a part of the bioreactors business
- Financial managers that are looking to study and publish recent and forecasted numbers pertaining to biotechnology
- Government organizations, regulatory authorities, policymakers and regional players looking for foreign investment
- Analysts, researchers, educators, strategy managers, and academic institutions looking for current and future insights into the market
The global bioreactors market size crossed USD 1.70 billion in 2017. Rising investment in biotechnology & pharmaceutical sector and significant demand for stainless steel as a choice of the reactor construction material are some of the key driving bioreactors market trends. North America and Europe accounted for a significant bioreactor market share among other regions in 2017, owing to high product utilization in pharmaceutical, biotechnology and research & development.
Global Bioreactors Market Trends, 2017- 2025 (USD Billion)
Single-use and multi-use bioreactors are the key product segments of the market. Single use bioreactor market is likely to increase at the fastest growth rate during the forecast period. A single-use bioreactor typically contains a disposable bag in place of a culture vessel. These products utilize a sterilized cell chamber in which the cell culture is maintained. The cell chamber reduces the cross-contamination risks as it is used for single growth operation. Furthermore, the use of single-use bioreactors optimizes the sterilization, cleaning, validation, and maintenance procedures needed for each bioreactor run.
The single use bioreactor market demand is expected to rise in pharmaceutical and R&D applications, owing to the key attributes of the product. High flexibility in terms of usage, less downtime, and controlled microbial contamination are some of the key attributes exhibited by the single-use bioreactors.
Multi-use or reusable bioreactors can be used numerous times. Reusable bioreactors require expensive and bulky clean-in-place (CIP) or steam-in-place (SIP) installations. The disposable bag of the single-use bioprocessors avoids the need to use CIP and SIP systems. The disposable bags are usually made of a three-layer plastic foil, with the layers frequently consisting of polyethylene, PVA, PVC, and polypropylene combinations to minimize leakage. The multi-use bioreactor segment accounted for more than two-third share of the global bioreactors market size in 2017.
The end-uses or applications that have supported strong bioreactors market trends include contract research organizations (CROs), biotechnology & pharmaceutical, and others. Contract research organizations (CROs) are a key constituent of the drug development process, providing a range of services to pharmaceutical, biotechnology, and medical device companies, as well as governments, academic institutions, and other research entities.
Single-use bioreactors are extensively used in CROs. CROs typically handle different products on account of which it is economical to use disposable bags in place of a stainless-steel vessel. The growing number of CROs is expected to augment the growth of the single use bioreactor market industry over the next few years.
U.S. was the largest market for biopharmaceuticals in North America. A large number of pipelines within the healthcare sector is expected to give rise to a large number of clinical trials which is likely to boost the global bioreactors market size by 2025. In addition, increasing trends of outsourcing by biopharma companies to CROs is expected to enhance the bioreactors market trends in the country, over the years ahead. North America and Europe are anticipated to portray strong bioreactors market trends during the forecast period.
Global Bioreactor Market Share, By Region, 2017 (%)
Europe has made significant advances in health outcomes over the past 60 years. The life expectancy of individuals has increased by nearly a decade, and effective treatments have become available for many of the most common infectious diseases. At the same time, biomedical R&D is breaking new ground in understanding patients’ specific genetic characteristics, paving the way for targeted, more effective therapies based on personalized medicine. Europe needs to continue this trend, but it will require new models for innovation and adaptation on all levels across the healthcare delivery chain. These factors are expected to boost the bioreactor market share of Europe by the end of 2025.
Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Limited, Danaher (Pall Corporation), Eppendorf AG, Praj HiPurity Systems Limited, Pierre Guerin, Zeta Holding GmbH, and Applikon Biotechnology B.V. are the key players that accounted for a significant share of the global bioreactors market size in 2017.
Key segments of the global bioreactors market for non-food applications report
Product Overview, 2012-2025 (USD Million)
- Single-use
- Multi-use
Construction Material Overview, 2012-2025 (USD Million)
- Stainless steel
- Glass
- Others
Application Overview, 2012-2025 (USD Million)
- Biotechnology & pharmaceutical
- Contract research organizations (CROs)
- Others
Regional Overview, 2012-2025 (USD Million)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- South Korea
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Rest of MEA
Reasons for the study
The purpose of the study is to provide a broad view of the global bioreactors market.
- We have been analyzing the recent growth trends of biotechnology, pharmaceutical, and research & development sectors. This further helped us in understanding the usage of bioreactors.
- Modification in bioreactors designs, adoption of the product in each geography are some of the trends analyzed while working on the study
- Competence of the top global players through their product offerings and geographical coverage are some of the other industry trends that have been taken into consideration for studying the bioreactors market
What does the report include?
- The study on the global bioreactors market includes qualitative market dynamics such as drivers, restraints, and opportunities
- Additionally, the market has been evaluated using the value chain, PESTEL analysis and Porter’s Five Forces analysis
- The study includes qualitative and quantitative analysis of the market categorized on the basis of product type, construction material, application and region
- Actual market sizes and forecast figures have been provided for all the afore-mentioned market segments
- The report also covers profiling of key industry players that have a significant global and/or regional presence
Who should buy this report?
This study is suitable for industry participants and stakeholders in the biotechnology, CROs and pharmaceutical industries, who want an in-depth insight into the development of the bioreactors market. The report will benefit:
- Executives of companies that are a part of the bioreactors business
- Financial managers that are looking to study and publish recent and forecasted numbers pertaining to biotechnology
- Government organizations, regulatory authorities, policymakers and regional players looking for foreign investment
- Analysts, researchers, educators, strategy managers, and academic institutions looking for current and future insights into the market
Chapter 1 Research Methodology
1.1 Research approach
1.2 Scope, definition, and assumptions
1.3 Data sources
Chapter 2 Executive Summary
Chapter 3 Market Outlook
3.1 Introduction
3.2 Key trends
3.2.1 Market drivers
3.2.2 Market restraints
3.2.3 Market opportunities
3.3 Value chain analysis
3.4 Porter’s Five Forces analysis
3.5 PESTEL analysis
Chapter 4 Product Overview
4.1 Market share, by product type, 2017 & 2025 (%)
4.2 Single-use
4.3 Multi-use
Chapter 5 Construction Material Overview
5.1 Market share, by construction material, 2017 & 2025 (%)
5.2 Stainless steel
5.3 Glass
5.4 Others
Chapter 6 Application Overview
6.1 Market share, by application, 2017 & 2025 (%)
6.2 Biotechnology & pharmaceutical
6.3 Contract research organizations (CROs)
6.4 Others
Chapter 7 Regional Overview
7.1 Market share by region, 2017 & 2025 (%)
7.2 North America
7.2.1 North America bioreactors market estimates and forecast, 2012 – 2025
7.2.2 North America bioreactors market estimates and forecast, by product, 2012 – 2025
7.2.3 North America bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.2.4 North America bioreactors market estimates and forecast, by application, 2012 – 2025
7.2.5 U.S.
7.2.5.1 U.S. bioreactors market estimates and forecast, 2012 – 2025
7.2.5.2 U.S. bioreactors market estimates and forecast, by product, 2012 – 2025
7.2.5.3 U.S. bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.2.5.4 U.S. bioreactors market estimates and forecast, by application, 2012 – 2025
7.2.6 Canada
7.2.6.1 Canada bioreactors market estimates and forecast, 2012 – 2025
7.2.6.2 Canada bioreactors market estimates and forecast, by product, 2012 – 2025
7.2.6.3 Canada bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.2.6.4 Canada bioreactors market estimates and forecast, by application, 2012 – 2025
7.2.7 Mexico
7.2.7.1 Mexico bioreactors market estimates and forecast, 2012 – 2025
7.2.7.2 Mexico bioreactors market estimates and forecast, by product, 2012 – 2025
7.2.7.3 Mexico bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.2.7.4 Mexico bioreactors market estimates and forecast, by application, 2012 – 2025
7.3 Europe
7.3.1 Europe bioreactors market estimates and forecast, 2012 – 2025
7.3.2 Europe bioreactors market estimates and forecast, by product, 2012 – 2025
7.3.3 Europe bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.3.4 Europe bioreactors market estimates and forecast, by application, 2012 – 2025
7.3.5 Germany
7.3.5.1 Germany bioreactors market estimates and forecast, 2012 – 2025
7.3.5.2 Germany bioreactors market estimates and forecast, by product, 2012 – 2025
7.3.5.3 Germany bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.3.5.4 Germany bioreactors market estimates and forecast, by application, 2012 – 2025
7.3.6 UK
7.3.6.1 UK bioreactors market estimates and forecast, 2012 – 2025
7.3.6.2 UK bioreactors market estimates and forecast, by product, 2012 – 2025
7.3.6.3 UK bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.3.6.4 UK bioreactors market estimates and forecast, by application, 2012 – 2025
7.3.7 France
7.3.7.1 France bioreactors market estimates and forecast, 2012 – 2025
7.3.7.2 France bioreactors market estimates and forecast, by product, 2012 – 2025
7.3.7.3 France bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.3.7.4 France bioreactors market estimates and forecast, by application, 2012 – 2025
7.3.8 Italy
7.3.8.1 Italy bioreactors market estimates and forecast, 2012 – 2025
7.3.8.2 Italy bioreactors market estimates and forecast, by product, 2012 – 2025
7.3.8.3 Italy bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.3.8.4 Italy bioreactors market estimates and forecast, by application, 2012 – 2025
7.3.9 Russia
7.3.9.1 Russia bioreactors market estimates and forecast, 2012 – 2025
7.3.9.2 Russia bioreactors market estimates and forecast, by product, 2012 – 2025
7.3.9.3 Russia bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.3.9.4 Russia bioreactors market estimates and forecast, by application, 2012 – 2025
7.3.10 Rest of Europe
7.3.10.1 Rest of Europe bioreactors market estimates and forecast, 2012 – 2025
7.3.10.2 Rest of Europe bioreactors market estimates and forecast, by product, 2012 – 2025
7.3.10.3 Rest of Europe bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.3.10.4 Rest of Europe bioreactors market estimates and forecast, by application, 2012 – 2025
7.4 Asia Pacific
7.4.1 Asia Pacific bioreactors market estimates and forecast, 2012 – 2025
7.4.2 Asia Pacific bioreactors market estimates and forecast, by product, 2012 – 2025
7.4.3 Asia Pacific bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.4.4 Asia Pacific bioreactors market estimates and forecast, by application, 2012 – 2025
7.4.5 China
7.4.5.1 China bioreactors market estimates and forecast, 2012 – 2025
7.4.5.2 China bioreactors market estimates and forecast, by product, 2012 – 2025
7.4.5.3 China bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.4.5.4 China bioreactors market estimates and forecast, by application, 2012 – 2025
7.4.6 South Korea
7.4.6.1 South Korea bioreactors market estimates and forecast, 2012 – 2025
7.4.6.2 South Korea bioreactors market estimates and forecast, by product, 2012 – 2025
7.4.6.3 South Korea bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.4.6.4 South Korea bioreactors market estimates and forecast, by application, 2012 – 2025
7.4.7 Japan
7.4.7.1 Japan bioreactors market estimates and forecast, 2012 – 2025
7.4.7.2 Japan bioreactors market estimates and forecast, by product, 2012 – 2025
7.4.7.3 Japan bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.4.7.4 Japan bioreactors market estimates and forecast, by application, 2012 – 2025
7.4.8 India
7.4.8.1 India bioreactors market estimates and forecast, 2012 – 2025
7.4.8.2 India bioreactors market estimates and forecast, by product, 2012 – 2025
7.4.8.3 India bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.4.8.4 India bioreactors market estimates and forecast, by application, 2012 – 2025
7.4.9 Rest of Asia Pacific
7.4.9.1 Rest of Asia Pacific bioreactors market estimates and forecast, 2012 – 2025
7.4.9.2 Rest of Asia Pacific bioreactors market estimates and forecast, by product, 2012 – 2025
7.4.9.3 Rest of Asia Pacific bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.4.9.4 Rest of Asia Pacific bioreactors market estimates and forecast, by application, 2012 – 2025
7.5 Latin America
7.5.1 Latin America bioreactors market estimates and forecast, 2012 – 2025
7.5.2 Latin America bioreactors market estimates and forecast, by product, 2012 – 2025
7.5.3 Latin America bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.5.4 Latin America bioreactors market estimates and forecast, by application, 2012 – 2025
7.5.5 Brazil
7.5.5.1 Brazil bioreactors market estimates and forecast, 2012 – 2025
7.5.5.2 Brazil bioreactors market estimates and forecast, by product, 2012 – 2025
7.5.5.3 Brazil bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.5.5.4 Brazil bioreactors market estimates and forecast, by application, 2012 – 2025
7.5.6 Rest of Latin America
7.5.6.1 Rest of Latin America bioreactors market estimates and forecast, 2012 – 2025
7.5.6.2 Rest of Latin America bioreactors market estimates and forecast, by product, 2012 – 2025
7.5.6.3 Rest of Latin America bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.5.6.4 Rest of Latin America bioreactors market estimates and forecast, by application, 2012 – 2025
7.6 Middle East and Africa (MEA)
7.6.1 MEA bioreactors market estimates and forecast, 2012 – 2025
7.6.2 MEA bioreactors market estimates and forecast, by product, 2012 – 2025
7.6.3 MEA bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.6.4 MEA bioreactors market estimates and forecast, by application, 2012 – 2025
7.6.5 South Africa
7.6.5.1 South Africa bioreactors market estimates and forecast, 2012 – 2025
7.6.5.2 South Africa bioreactors market estimates and forecast, by product, 2012 – 2025
7.6.5.3 South Africa bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.6.5.4 South Africa bioreactors market estimates and forecast, by application, 2012 – 2025
7.6.6 Rest of MEA
7.6.6.1 Rest of MEA bioreactors market estimates and forecast, 2012 – 2025
7.6.6.2 Rest of MEA bioreactors market estimates and forecast, by product, 2012 – 2025
7.6.6.3 Rest of MEA bioreactors market estimates and forecast, by construction material, 2012 – 2025
7.6.6.4 Rest of MEA bioreactors market estimates and forecast, by application, 2012 – 2025
Chapter 8 Market Competition
8.1 Company market share, 2017
8.2 Strategic framework
Chapter 9 Company Profiles
9.1 Sartorius AG
9.1.1 Company overview
9.1.2 Product portfolio
9.1.3 Financial performance
9.2 Thermo Fisher Scientific Inc.
9.2.1 Company overview
9.2.2 Product portfolio
9.2.3 Financial performance
9.3 Merck KGaA
9.3.1 Company overview
9.3.2 Product portfolio
9.3.3 Financial performance
9.4 GE Healthcare
9.5.1 Company overview
9.5.2 Product portfolio
9.5.3 Financial performance
9.5 Danaher (Pall)
9.5.1 Company overview
9.5.2 Product portfolio
9.5.3 Financial performance
9.6 Eppendorf AG
9.6.1 Company overview
9.6.2 Product portfolio
9.6.3 Financial performance
9.7 Praj Hipurity Systems
9.7.1 Company overview
9.7.2 Product portfolio
9.7.3 Financial performance
9.8 Pierre Guerin (DCI-Biolafitte)
9.9.1 Company overview
9.9.2 Product portfolio
9.9.3 Financial performance
9.9 ZETA
9.9.1 Company overview
9.9.2 Product portfolio
9.9.3 Financial performance
9.10 Bioengineering AG
9.10.1 Company overview
9.10.2 Product portfolio
9.10.3 Financial performance
9.11 Infors HT
9.11.1 Company overview
9.11.2 Product portfolio
9.11.3 Financial performance
9.12 Solaris Biotech
9.12.1 Company overview
9.12.2 Product portfolio
9.12.3 Financial performance
9.13 Spar Mixers
9.13.1 Company overview
9.13.2 Product portfolio
9.13.3 Financial performance